What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Endocrinology
- Cancer
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Primary hyperparathyroidism, Osteoporosis and Hyperparathyroidism.
Many of his studies on Internal medicine involve topics that are commonly interrelated, such as Surgery.
His research integrates issues of Calcimimetic and Cancellous bone in his study of Endocrinology.
He combines subjects such as Urology, Parathyroidectomy, Asymptomatic, Pathology and Femoral neck with his study of Primary hyperparathyroidism.
His research investigates the connection with Osteoporosis and areas like MEDLINE which intersect with concerns in Hypoparathyroidism.
His Hyperparathyroidism research is multidisciplinary, incorporating perspectives in Prospective cohort study and Calcium.
His most cited work include:
- Primer on the metabolic bone diseases and disorders of mineral metabolism (1854 citations)
- CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2 (1532 citations)
- Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. (1110 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Endocrinology, Osteoporosis, Primary hyperparathyroidism and Parathyroid hormone.
His study in Internal medicine concentrates on Bone remodeling, Bone mineral, Bone density, Vitamin D and neurology and Calcium.
In his study, Urology is inextricably linked to Femoral neck, which falls within the broad field of Bone mineral.
As part of his studies on Endocrinology, John P. Bilezikian often connects relevant subjects like Receptor.
The study incorporates disciplines such as Anabolism, Bioinformatics and Intensive care medicine in addition to Osteoporosis.
John P. Bilezikian has researched Primary hyperparathyroidism in several fields, including Parathyroidectomy, Hyperparathyroidism, Asymptomatic and Disease.
He most often published in these fields:
- Internal medicine (58.47%)
- Endocrinology (51.33%)
- Osteoporosis (31.23%)
What were the highlights of his more recent work (between 2013-2021)?
- Internal medicine (58.47%)
- Endocrinology (51.33%)
- Osteoporosis (31.23%)
In recent papers he was focusing on the following fields of study:
John P. Bilezikian mainly investigates Internal medicine, Endocrinology, Osteoporosis, Primary hyperparathyroidism and Parathyroid hormone.
His studies deal with areas such as Gastroenterology and MEDLINE as well as Internal medicine.
Within one scientific family, John P. Bilezikian focuses on topics pertaining to Placebo under Endocrinology, and may sometimes address concerns connected to Randomized controlled trial.
His Primary hyperparathyroidism research includes elements of Urology, Parathyroidectomy, Hyperparathyroidism, Asymptomatic and Disease.
His research in Parathyroid hormone intersects with topics in Cancellous bone, Pathology, Endocrine system and Skeleton.
The various areas that John P. Bilezikian examines in his Bone mineral study include Postmenopausal women and Femoral neck.
Between 2013 and 2021, his most popular works were:
- Extrapulmonary manifestations of COVID-19. (533 citations)
- Trabecular bone score: a noninvasive analytical method based upon the DXA image. (399 citations)
- Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus (239 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Endocrinology
- Cancer
John P. Bilezikian spends much of his time researching Internal medicine, Endocrinology, Osteoporosis, Parathyroid hormone and Hypoparathyroidism.
His biological study spans a wide range of topics, including Diabetes mellitus, Canagliflozin and Type 2 Diabetes Mellitus.
The Endocrinology study combines topics in areas such as Placebo, Randomized controlled trial and MEDLINE.
His Osteoporosis research incorporates elements of Surgery, Physical therapy and Radiology.
His Radiology study combines topics in areas such as Osteitis fibrosa cystica, Primary hyperparathyroidism and Bone disease.
His Parathyroid hormone research is multidisciplinary, relying on both Parathyroid hormone receptor, Bone resorption and RANKL.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
